MedPath

Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man

Phase 3
Completed
Conditions
Hypogonadism
Interventions
Biological: Testosterone (Insulin sensitivity)
Biological: Estradiol (Insulin sensitivity)
Registration Number
NCT02847806
Lead Sponsor
University Hospital, Caen
Brief Summary

Sexual steroids administered to supra-physiological doses are likely to change the carbohydrate and lipid metabolism.

Investigators propose to study in 12 hypogonadal men hypogonadotropic or hypergonadotropic treated with aromatase inhibitor, the respective effects of estradiol, testosterone or both steroids administered in a cross-over Latin squares plan on insulin sensitivity measured by the reference method of the hyperinsulinemic euglycemic clamp.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
6
Inclusion Criteria
  • Hypogonadism hypogonadotropic or hypergonadotropic
  • Man aged 18-60 years
  • BMI between 18 and 27.
Exclusion Criteria
  • Other ante-pituitary deficiency
  • Chronic treatment modifying carbohydrate metabolism (thiazides, beta 2 mimetics, steroids ...)
  • Diabetes
  • Obesity diffuse or android
  • Hemochromatosis
  • osteoporosis
  • chronic diseases
  • neoplasia
  • High blood pressure

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
TestosteroneTestosterone (Insulin sensitivity)dosage used : from 25 to 75 mg / day of testosterone (ie 2.5 to 7.5 g / day transdermal gel) according to the plasma level, with the goal of a physiological level of testosterone (5-8 ng / ml) - During 4 weeks
Testosterone + EstradiolEstradiol (Insulin sensitivity)Testosterone + Estradiol During 4 weeks
EstradiolEstradiol (Insulin sensitivity)dosage used in the study: 1 patch / 3-4 days dosed at 25, 37.5 or 50 mg / 24h titration according to the plasma level, with the objective of a physiological level of estradiol (25-40 pg / ml ) - During 4 weeks
Testosterone + EstradiolTestosterone (Insulin sensitivity)Testosterone + Estradiol During 4 weeks
Primary Outcome Measures
NameTimeMethod
GIR (glucose infusion rate) during euglycemic hyperinsulinemic clampchange between baseline and after 4 weeks of treatments
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen

🇫🇷

Caen, France

© Copyright 2025. All Rights Reserved by MedPath